Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-17

FDA Approved: ZOLMITRIPTAN OD — Original Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista's generic Zolmitriptan OD for the acute treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan OD (Zolmitriptan)

Snippet

ORIG AP for ZOLMITRIPTAN OD (ZOLMITRIPTAN)